Sphaera Biosciences Inc., USA

Sphaera Pharma Pvt Ltd Announces Formation of Sphaera Biosciences Inc., USA. . .

Gurugram, India – June 2025 – Sphaera Pharma Pvt Ltd, a pioneering integrated drug discovery and development company based in India, proudly announces the establishment of its wholly owned subsidiary, Sphaera Bio Sciences, USA. This strategic expansion underscores Sphaera Pharma’s commitment to strengthening its global presence and accelerating innovation in pharmaceutical research. Sphaera Bio Sciences, USA will focus on advancing novel drug discovery programs and harnessing the latest technologies to address critical unmet medical needs. This new entity will synergize the scientific strengths of Sphaera Pharma’s Indian operations with direct access to the dynamic US biotech and pharmaceutical markets. Founded in 2007 and headquartered in Gurugram, Haryana, India, Sphaera Pharma Pvt Ltd is recognized for its expertise in drug discovery and development, supported by a talented team of chemists, pharmacologists, and drug hunters with international experience. The creation of Sphaera Bio Sciences, USA reflects the company’s dedication to expanding its scientific capabilities and global footprint. For further information, please contact: info@sphaerapharma.com www.sphaerapharma.com

Bio International Convention, Boston 2025

Sphaera participates at the Bio International Convention from June 16th to 19th, 2025 at the Boston Convention Centre. . .

Exciting Times for Sphaera Pharma at Bio Boston 2025! As we continue to innovate and push the boundaries of pharmaceutical development, we are proud to be part of the vibrant Bio Boston community! Team Sphaera had exciting meetings with researchers across the globe and showcased our truly integrated drug discovery capabilities. We are committed to fostering partnerships that drive progress and bring hope to patients worldwide. Let’s connect and collaborate to innovate for patients.

Bio International Convention 2024

Meet us at Bio International convention from 3rd-6th June 2024 at San Diego Convention Center CA . . .

Our CEO Abhinav Dhandia will be there to meet industry experts and expand collaborations at the place where Business and Breakthroughs Converge.

DDC, San Diego, 2024

Frank Hollinger, PhD attended at the 19th Annual Drug Discovery Chemistry Conference from 1st-4th April 2024 . . .

It was a prominent chance to capitalize with industry peers.

focused on optimizing small molecules for tomorrow’s therapeutics.

Showcasing Sphaera at Reach 2024

Dr. Somdutta Sen (Director and Head of R&D), Sphaera Pharma, delivered a lecture at the 5th International Conference . . .

“REACH 2024- Precision Healthcare" from 15-16th March 2024, organized by GD Goenka University, on

“Targeted Therapy for Effective Treatment of a Rare Form of Bone Cancer-Chordoma”.

Sphaera’s presence at recent pharma events - CPHI and Global Bio

Team Sphaera participated in CPHI and Global Bio-India . . .

engaging in insightful discussions and networking with industry professionals.

Value over Volume

Our CEO Abhinav Dhandia attended the 20th edition of BioAsia2023 from 24-26th Feb 2023 for Sphaera Pharma . . .

The entire pharma life sciences ecosystem was together to pour out ideas, innovations, and interactions.

Improving Cognizance on Drug Repurposing

Dr. Somdutta Sen (Director and Head of R&D), delivered a lecture on ‘Drug Repurposing’ . . . .

at National Brain Research Centre (NBRC) Manesar from Feb 6-17th, 2023.

Drug repurposing opens new doors to an approved drug for a different indication or rescuing a candidate that may have failed in Clinic and developing it to treat a different condition.